ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 798

Altered Phenotype of Platelets and Neutrophils Toward Neutrophil-Platelet Interaction in Circulation of Small and Large Vessel Vasuculitis

Kotaro Matsumoto1, Hidekata Yasuoka2, Komei Sakata1, Keiko Yoshimoto1,3, Katsuya Suzuki1,4, Kunihiro Yamaoka1 and Tsutomu Takeuchi1, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 235 Shinanomachi, Shinjuku, Keio University School of Medicine, Tokyo, Japan, 3Keio University School of Medicine, Clinical and Translational Research Center, Tokyo, Japan, 4Division of Rheumatology, Department of Internal Medicine, Keio University School of Medcine, Tokyo, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: NETosis, neutrophils, platelets and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Vasculitis Poster I: Large Vessel Vasculitis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Neutrophils play an important role in the pathogenesis of necrotizing vasculitis, and activation of neutrophil is one of important triggers of the disease process. Recent reports suggest that platelets can stimulate neutrophils directly via aggregation by these cells or indirectly via chemokines produced by platelets. Thus, we hypothesized that activation of neutrophils by platelets may contribute to the progression of vasculitis. Our aim of this study is to clarify the phenotype alteration of circulating platelets and neutrophils toward aggregation in patients with vasculitis.

Methods: Untreated patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and large vessel vasuculitis (LVV) who visited Keio University Hospital between 2015 and 2017 were consecutively involved and compared with 33 healthy controls (HC). Patients with AAV and LVV fulfilled 2012 Revisited International Chapel Hill Consensus Normenclature or American College of Rheumatology 1990 criteria. Platelet-rich plasma and neutrophils were isolated from heparinized whole blood using gradient centrifugation. Expression levels of CD62P on platelets and CD41a on neutrophils which involved in platelet-neutrophil interaction were analyzed by FACS. The correlation between expression levels of CD62P and CD41a on these cells and clinical parameters of the patients were also analyzed.

Results: Four microscopic polyangitis (MPA), 2 granulomatosis with polyangitis (GPA) as AAV, and 5 giant cell arteritis (GCA), 3 Takayasu arteritis (TAK) as LVV were involved. As of AAV, mean age was 67 ± 8 years, 62% male, mean BVAS 15 ± 2, mean neutrophil counts 6,654 ± 1,262 /μL, and mean platelet counts 34 ± 6 × 104/μL. As of LVV, mean age 66 ± 4 years, 53% male, mean neutrophil counts 5,507 ± 600 /μL, and mean platelet counts 36 ± 5 × 104/μL. The treatment was started with 1 mg/kg/day of prednisolone for all patients. Proportion of CD62P+ platelets was remarkably higher in AAV (2.5 ± 0.09 versus 1.7 ± 1.0, p = 0.05) and LVV (3.2 ± 1.1 versus 1.7 ± 1.0, p = 0.005) compared with HC. Moreover, proportion of CD62P+ platelets was tended to be decreased by immunosuppressive treatment (2.6 ± 0.7 versus 2.0 ± 0.6, p = 0.1) along with improvement of disease activity. In addition, proportion of CD41a+ neutrophils also tended to be higher in AAV and LVV compared with HC (27 ± 8.8 versus 20 ± 5.8, p = 0.07), and decreased by the treatment (29 ± 9.2 versus 18 ± 6.8, p = 0.07). Interestingly, proportion of CD41a+ neutrophils was significantly and positively correlated with CD62P+ platelets (r2 = 0.8, p = 0.04) and ANCA titer (r2 = 0.9, p = 0.003) in AAV patients.

Conclusion: Phenotype of circulating platelets and neutrophils are altered toward cell to cell contact and associate with disease activity. These results suggest that platelet-neutrophil interaction is involved in the disease process of vasculitis.


Disclosure: K. Matsumoto, None; H. Yasuoka, None; K. Sakata, None; K. Yoshimoto, None; K. Suzuki, None; K. Yamaoka, None; T. Takeuchi, None.

To cite this abstract in AMA style:

Matsumoto K, Yasuoka H, Sakata K, Yoshimoto K, Suzuki K, Yamaoka K, Takeuchi T. Altered Phenotype of Platelets and Neutrophils Toward Neutrophil-Platelet Interaction in Circulation of Small and Large Vessel Vasuculitis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/altered-phenotype-of-platelets-and-neutrophils-toward-neutrophil-platelet-interaction-in-circulation-of-small-and-large-vessel-vasuculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/altered-phenotype-of-platelets-and-neutrophils-toward-neutrophil-platelet-interaction-in-circulation-of-small-and-large-vessel-vasuculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology